TreeWAS – Variant ID: rs7524694

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.342	0.658	0.000
Z50 Care involving use of rehabilitation procedures	0.328	0.672	0.000
Z50.1 Other physical therapy	0.323	0.677	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.293	0.707	0.000
Z50.5 Speech therapy	0.290	0.710	0.000
Z50.8 Care involving use of rehabilitation procedures	0.248	0.752	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.242	0.758	0.000
Z50.6 Orthoptic training	0.235	0.765	0.000
Z50.3 Drug rehabilitation	0.235	0.765	0.000
Z50.0 Cardiac rehabilitation	0.198	0.802	0.000
Z50.2 Alcohol rehabilitation	0.084	0.914	0.001
O63.1 Prolonged second stage (of labour)	0.000	0.963	0.037
M19.91 Arthrosis, unspecified (Shoulder region)	0.014	0.986	0.000
G44.2 Tension-type headache	0.014	0.986	0.000
G45.4 Transient global amnesia	0.013	0.987	0.000
C85.1 B-cell lymphoma, unspecified	0.013	0.987	0.000
O63 Long labour	0.000	0.987	0.013
G47 Sleep disorders	0.013	0.987	0.000
G44 Other headache syndromes	0.013	0.987	0.000
G47.9 Sleep disorder, unspecified	0.012	0.988	0.000
Y42.7 Androgens and anabolic congeners	0.012	0.988	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.012	0.988	0.000
J86.9 Pyothorax without fistula	0.011	0.988	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.011	0.989	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.011	0.989	0.000
G40-G47 Episodic and paroxysmal disorders	0.011	0.989	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.011	0.989	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.011	0.989	0.000
G47.4 Narcolepsy and cataplexy	0.011	0.989	0.000
G44.0 Cluster headache syndrome	0.011	0.989	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.010	0.990	0.000
C83.0 Small cell (diffuse)	0.010	0.990	0.000
G47.2 Disorders of the sleep-wake schedule	0.010	0.990	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.010	0.990	0.000
O63.0 Prolonged first stage (of labour)	0.000	0.990	0.010
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.010	0.990	0.000
Y42.5 Other oestrogens and progestogens	0.010	0.990	0.000
G47.3 Sleep apnoea	0.010	0.990	0.000
C83.3 Large cell (diffuse)	0.010	0.990	0.000
O63.2 Delayed delivery of second twin, triplet, etc.	0.000	0.990	0.009
R49.0 Dysphonia	0.010	0.990	0.000
G46 Vascular syndromes of brain in cerebrovascular diseases	0.010	0.990	0.000
G44.8 Other specified headache syndromes	0.009	0.991	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.009	0.991	0.000
G44.3 Chronic posttraumatic headache	0.009	0.991	0.000
G44.1 Vascular headache, not elsewhere classified	0.009	0.991	0.000
C83.1 Small cleaved cell (diffuse)	0.009	0.991	0.000
C81 Hodgkin's disease	0.009	0.991	0.000
G47.8 Other sleep disorders	0.009	0.991	0.000
C88 Malignant immunoproliferative diseases	0.009	0.991	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.009	0.991	0.000
C85.0 Lymphosarcoma	0.009	0.991	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
C95 Leukaemia of unspecified cell type	0.009	0.991	0.000
C93 Monocytic leukaemia	0.008	0.991	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.008	0.991	0.000
C83.7 Burkitt's tumour	0.008	0.992	0.000
C83.6 Undifferentiated (diffuse)	0.008	0.992	0.000
C83.5 Lymphoblastic (diffuse)	0.008	0.992	0.000
C83.4 Immunoblastic (diffuse)	0.008	0.992	0.000
C83.2 Mixed small and large cell (diffuse)	0.008	0.992	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.008	0.992	0.000
G45.1 Carotid artery syndrome (hemispheric)	0.008	0.992	0.000
G45.0 Vertebro-basilar artery syndrome	0.008	0.992	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.008	0.992	0.000
G46.7 Other lacunar syndromes	0.008	0.992	0.000
Y42.1 Thyroid hormones and substitutes	0.008	0.992	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.008	0.992	0.000
C94 Other leukaemias of specified cell type	0.008	0.992	0.000
C86 Other specified types of T/NK-cell lymphoma	0.008	0.992	0.000
G47.1 Disorders of excessive somnolence [hypersomnias]	0.008	0.992	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.008	0.992	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.008	0.992	0.000
G45.3 Amaurosis fugax	0.008	0.992	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.008	0.992	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.008	0.992	0.000
C81.1 Nodular sclerosis	0.008	0.992	0.000
C92 Myeloid leukaemia	0.008	0.992	0.000
Y42.9 Other and unspecified hormone antagonists	0.008	0.992	0.000
Y42.4 Oral contraceptives	0.008	0.992	0.000
Y42.2 Antithyroid drugs	0.008	0.992	0.000
C91 Lymphoid leukaemia	0.008	0.992	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.007	0.992	0.000
J86 Pyothorax	0.008	0.992	0.000
O63.9 Long labour, unspecified	0.000	0.993	0.007
G41 Status epilepticus	0.007	0.993	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.007	0.993	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.007	0.993	0.000
G46.8 Other vascular syndromes of brain in cerebrovascular diseases	0.007	0.993	0.000
G46.6 Pure sensory lacunar syndrome	0.007	0.993	0.000
G46.5 Pure motor lacunar syndrome	0.007	0.993	0.000
G46.4 Cerebellar stroke syndrome	0.007	0.993	0.000
G46.3 Brain stem stroke syndrome	0.007	0.993	0.000
G46.2 Posterior cerebral artery syndrome	0.007	0.993	0.000
G46.1 Anterior cerebral artery syndrome	0.007	0.993	0.000
G46.0 Middle cerebral artery syndrome	0.007	0.993	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.007	0.993	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.007	0.993	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.007	0.993	0.000
C81.9 Hodgkin's disease, unspecified	0.007	0.993	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.007	0.993	0.000
C95.9 Leukaemia, unspecified	0.007	0.993	0.000
C81.7 Other Hodgkin's disease	0.007	0.993	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.007	0.993	0.000
C81.3 Lymphocytic depletion	0.007	0.993	0.000
C81.2 Mixed cellularity	0.007	0.993	0.000
C81.0 Lymphocytic predominance	0.007	0.993	0.000
C90.2 Plasmacytoma, extramedullary	0.007	0.993	0.000
C93.1 Chronic monocytic leukaemia	0.007	0.993	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.007	0.993	0.000
C88.7 Other malignant immunoproliferative diseases	0.007	0.993	0.000
C88.3 Immunoproliferative small intestinal disease	0.007	0.993	0.000
C88.2 Gamma heavy chain disease	0.007	0.993	0.000
C88.1 Alpha heavy chain disease	0.007	0.993	0.000
C92.0 Acute myeloid leukaemia	0.007	0.993	0.000
C82.0 Small cleaved cell, follicular	0.007	0.993	0.000
C15.9 Oesophagus, unspecified	0.000	0.993	0.007
J86.0 Pyothorax with fistula	0.006	0.993	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.006	0.993	0.000
C95.7 Other leukaemia of unspecified cell type	0.006	0.993	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.006	0.993	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.006	0.993	0.000
C95.0 Acute leukaemia of unspecified cell type	0.006	0.993	0.000
C93.9 Monocytic leukaemia, unspecified	0.006	0.994	0.000
C93.7 Other monocytic leukaemia	0.006	0.994	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.006	0.994	0.000
C93.2 Subacute monocytic leukaemia	0.006	0.994	0.000
C93.0 Acute monocytic leukaemia	0.006	0.994	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.994	0.006
C90.3 Solitary plasmacytoma	0.006	0.994	0.000
C90.1 Plasma cell leukaemia	0.006	0.994	0.000
G43 Migraine	0.006	0.994	0.000
R49 Voice disturbances	0.006	0.994	0.000
Z36.8 Other antenatal screening	0.000	0.994	0.006
C92.4 Acute promyelocytic leukaemia	0.006	0.994	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.006	0.994	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.006	0.994	0.000
C86.4 Blastic NK-cell lymphoma	0.006	0.994	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.006	0.994	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.006	0.994	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.006	0.994	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.006	0.994	0.000
C94.7 Other specified leukaemias	0.006	0.994	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.006	0.994	0.000
C94.5 Acute myelofibrosis	0.006	0.994	0.000
C94.4 Acute panmyelosis	0.006	0.994	0.000
C94.3 Mast cell leukaemia	0.006	0.994	0.000
C94.2 Acute megakaryoblastic leukaemia	0.006	0.994	0.000
C94.1 Chronic erythraemia	0.006	0.994	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.006	0.994	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.006	0.994	0.000
C96.8 Histiocytic sarcoma	0.006	0.994	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.006	0.994	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.006	0.994	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.006	0.994	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.006	0.994	0.000
C96.3 True histiocytic lymphoma	0.006	0.994	0.000
C96.2 Malignant mast cell tumour	0.006	0.994	0.000
C96.1 Malignant histiocytosis	0.006	0.994	0.000
C96.0 Letterer-Siwe disease	0.006	0.994	0.000
C82.6 Cutaneous follicle centre lymphoma	0.006	0.994	0.000
C82.5 Diffuse follicle centre lymphoma	0.006	0.994	0.000
C82.4 Follicular lymphoma grade IIIb	0.006	0.994	0.000
C82.3 Follicular lymphoma grade IIIa	0.006	0.994	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.006	0.994	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.006	0.994	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.006	0.994	0.000
C84.3 Lymphoepithelioid lymphoma	0.006	0.994	0.000
C84.2 T-zone lymphoma	0.006	0.994	0.000
C84.1 Sezary's diease	0.006	0.994	0.000
C84.0 Mycosis fungoides	0.006	0.994	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.000	0.994	0.006
C91.4 Hairy-cell leukaemia	0.006	0.994	0.000
C82.2 Large cell, follicular	0.006	0.994	0.000
C92.9 Myeloid leukaemia, unspecified	0.006	0.994	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.006	0.994	0.000
C92.7 Other myeloid leukaemia	0.006	0.994	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.006	0.994	0.000
C92.5 Acute myelomonocytic leukaemia	0.006	0.994	0.000
C92.3 Myeloid sarcoma	0.006	0.994	0.000
C92.2 Subacute myeloid leukaemia	0.006	0.994	0.000
C84.4 Peripheral T-cell lymphoma	0.006	0.994	0.000
C90.0 Multiple myeloma	0.006	0.994	0.000
C91.9 Lymphoid leukaemia, unspecified	0.006	0.994	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.006	0.994	0.000
C91.7 Other lymphoid leukaemia	0.006	0.994	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.006	0.994	0.000
C91.5 Adult T-cell leukaemia	0.006	0.994	0.000
C91.3 Prolymphocytic leukaemia	0.006	0.994	0.000
C91.2 Subacute lymphocytic leukaemia	0.006	0.994	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.006	0.994	0.000
Z36 Antenatal screening	0.000	0.994	0.006
G41.8 Other status epilepticus	0.005	0.994	0.000
G41.2 Complex partial status epilepticus	0.005	0.994	0.000
G41.1 Petit mal status epilepticus	0.005	0.994	0.000
G41.0 Grand mal status epilepticus	0.005	0.994	0.000
C91.0 Acute lymphoblastic leukaemia	0.005	0.994	0.000
G43.1 Migraine with aura [classical migraine]	0.005	0.995	0.000
W22.9 Unspecified place	0.005	0.995	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.995	0.005
R49.1 Aphonia	0.005	0.995	0.000
C91.1 Chronic lymphocytic leukaemia	0.005	0.995	0.000
C84.5 Other and unspecified T-cell lymphomas	0.005	0.995	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.005	0.995	0.000
G43.8 Other migraine	0.005	0.995	0.000
G43.3 Complicated migraine	0.005	0.995	0.000
G43.2 Status migrainosus	0.005	0.995	0.000
G43.0 Migraine without aura [common migraine]	0.005	0.995	0.000
R49.2 Hypernasality and hyponasality	0.005	0.995	0.000
R47 Speech disturbances, not elsewhere classified	0.005	0.995	0.000
R47.0 Dysphasia and aphasia	0.005	0.995	0.000
R47-R49 Symptoms and signs involving speech and voice	0.005	0.995	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.005	0.995	0.000
G41.9 Status epilepticus, unspecified	0.004	0.995	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.995	0.004
M05.9 Seropositive rheumatoid arthritis, unspecified	0.004	0.996	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.996	0.004
C15 Malignant neoplasm of oesophagus	0.000	0.996	0.004
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
W22 Striking against or struck by other objects	0.004	0.996	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.996	0.004
R47.8 Other and unspecified speech disturbances	0.004	0.996	0.000
C15.4 Middle third of oesophagus	0.000	0.996	0.004
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.996	0.004
E29.1 Testicular hypofunction	0.004	0.996	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.996	0.004
J35.0 Chronic tonsillitis	0.000	0.996	0.004
R47.1 Dysarthria and anarthria	0.004	0.996	0.000
D75.8 Other specified diseases of blood and blood-forming organs	0.004	0.996	0.000
W22.5 Trade and service area	0.004	0.996	0.000
W22.2 School, other institution and public administrative area	0.004	0.996	0.000
O42.9 Premature rupture of membranes, unspecified	0.004	0.996	0.000
M94.88 Other specified disorders of cartilage (Other)	0.004	0.996	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.004	0.996	0.000
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.003	0.996	0.000
R49.8 Other and unspecified voice disturbances	0.003	0.996	0.000
I45.1 Other and unspecified right bundle-branch block	0.004	0.996	0.000
M94.8 Other specified disorders of cartilage	0.003	0.996	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.003	0.997	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.003	0.997	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.003	0.997	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.003	0.997	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.003	0.997	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
C15.5 Lower third of oesophagus	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.001
M94.86 Other specified disorders of cartilage (Lower leg)	0.003	0.997	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.997	0.003
C15.3 Upper third of oesophagus	0.000	0.997	0.003
C15.2 Abdominal part of oesophagus	0.000	0.997	0.003
C15.1 Thoracic part of oesophagus	0.000	0.997	0.003
C15.0 Cervical part of oesophagus	0.000	0.997	0.003
W22.8 Other specified place	0.003	0.997	0.000
W22.6 Industrial and construction area	0.003	0.997	0.000
W22.4 Street and highway	0.003	0.997	0.000
W22.0 Home	0.003	0.997	0.000
W22.7 Farm	0.003	0.997	0.000
W22.3 Sports and athletics area	0.003	0.997	0.000
W22.1 Residential institution	0.003	0.997	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.003	0.997	0.000
Z88.5 Personal history of allergy to narcotic agent	0.000	0.997	0.003
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.003	0.997	0.000
J38.4 Oedema of larynx	0.003	0.997	0.000
Z71.8 Other specified counselling	0.000	0.997	0.003
R48.8 Other and unspecified symbolic dysfunctions	0.003	0.997	0.000
R48.2 Apraxia	0.003	0.997	0.000
R48.1 Agnosia	0.003	0.997	0.000
R48.0 Dyslexia and alexia	0.003	0.997	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.003	0.997	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.003	0.997	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.003	0.997	0.000
M94.83 Other specified disorders of cartilage (Forearm)	0.003	0.997	0.000
M94.82 Other specified disorders of cartilage (Upper arm)	0.003	0.997	0.000
M94.81 Other specified disorders of cartilage (Shoulder region)	0.003	0.997	0.000
M94.80 Other specified disorders of cartilage (Multiple sites)	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.003	0.997	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.997	0.003
T78 Adverse effects, not elsewhere classified	0.003	0.997	0.000
T78.2 Anaphylactic shock, unspecified	0.003	0.997	0.000
W22.09 Striking against or struck by other objects; Home; During unspecified activity	0.002	0.997	0.000
W22.03 Striking against or struck by other objects; Home; While engaged in other types of work	0.002	0.997	0.000
W22.41 Striking against or struck by other objects; Street and highway;While engaged in leisure activity	0.002	0.997	0.000
W22.62 Striking against or struck by other objects; Industrial and construction area ;While working for income	0.002	0.997	0.000
W22.88 Striking against or struck by other objects; Other specified places ;While engaged in other specified activities	0.002	0.997	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
M05 Seropositive rheumatoid arthritis	0.003	0.997	0.000
C43.4 Malignant melanoma of scalp and neck	0.000	0.997	0.003
D75.1 Secondary polycythaemia	0.003	0.997	0.000
D75 Other diseases of blood and blood-forming organs	0.003	0.997	0.000
T78.4 Allergy, unspecified	0.003	0.997	0.000
D32.9 Meninges, unspecified	0.003	0.997	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.002	0.997	0.000
T78.3 Angioneurotic oedema	0.002	0.997	0.000
J38.7 Other diseases of larynx	0.002	0.998	0.000
Z99.3 Dependence on wheelchair	0.002	0.998	0.000
W20-W49 Exposure to inanimate mechanical forces	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
C43 Malignant melanoma of skin	0.000	0.998	0.002
E29 Testicular dysfunction	0.002	0.998	0.000
J85 Abscess of lung and mediastinum	0.002	0.998	0.000
I67.8 Other specified cerebrovascular diseases	0.002	0.998	0.000
R13 Dysphagia	0.002	0.998	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.002	0.998	0.000
I45.5 Other specified heart block	0.002	0.998	0.000
O26.8 Other specified pregnancy-related conditions	0.000	0.998	0.002
T78.8 Other adverse effects, not elsewhere classified	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
C43.5 Malignant melanoma of trunk	0.000	0.998	0.002
Y45.4 Antirheumatics	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
I42.2 Other hypertrophic cardiomyopathy	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
F41.9 Anxiety disorder, unspecified	0.002	0.998	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.002	0.998	0.000
T78.9 Adverse effect, unspecified	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.002	0.998	0.000
D75.9 Disease of blood and blood-forming organs, unspecified	0.002	0.998	0.000
I95.1 Orthostatic hypotension	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
M94 Other disorders of cartilage	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
D75.0 Familial erythrocytosis	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.000	0.998	0.002
A49.8 Other bacterial infections of unspecified site	0.002	0.998	0.000
C43.9 Malignant melanoma of skin, unspecified	0.000	0.998	0.002
K91.4 Colostomy and enterostomy malfunction	0.002	0.998	0.000
M41.9 Scoliosis, unspecified	0.002	0.998	0.000
F03 Unspecified dementia	0.002	0.998	0.000
M87.96 Osteonecrosis, unspecified (Lower leg)	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.002	0.998	0.000
M89 Other disorders of bone	0.002	0.998	0.000
M05.8 Other seropositive rheumatoid arthritis	0.002	0.998	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
M05.1 Rheumatoid lung disease	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
M87.9 Osteonecrosis, unspecified	0.002	0.998	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.002	0.998	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.998	0.002
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
A49 Bacterial infection of unspecified site	0.002	0.998	0.000
A46 Erysipelas	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.002	0.998	0.000
M87 Osteonecrosis	0.002	0.998	0.000
W45 Foreign body or object entering through skin	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
M89.3 Hypertrophy of bone	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
W46 Contact with hypodermic needle	0.002	0.998	0.000
W43 Exposure to vibration	0.002	0.998	0.000
W42 Exposure to noise	0.002	0.998	0.000
W41 Exposure to high-pressure jet	0.002	0.998	0.000
W40 Explosion of other materials	0.002	0.998	0.000
W39 Discharge of firework	0.002	0.998	0.000
W38 Explosion and rupture of other specified pressurised devices	0.002	0.998	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.002	0.998	0.000
W36 Explosion and rupture of gas cylinder	0.002	0.998	0.000
W35 Explosion and rupture of boiler	0.002	0.998	0.000
W34 Discharge from other and unspecified firearms	0.002	0.998	0.000
W33 Rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
W32 Handgun discharge	0.002	0.998	0.000
W31 Contact with other and unspecified machinery	0.002	0.998	0.000
W30 Contact with agricultural machinery	0.002	0.998	0.000
W28 Contact with powered lawn mower	0.002	0.998	0.000
W27 Contact with nonpowered hand tool	0.002	0.998	0.000
W26 Contact with knife, sword or dagger	0.002	0.998	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.002	0.998	0.000
W21 Striking against or struck by sports equipment	0.002	0.998	0.000
H81.1 Benign paroxysmal vertigo	0.002	0.998	0.000
J38.3 Other diseases of vocal cords	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.002	0.998	0.000
J85.3 Abscess of mediastinum	0.002	0.998	0.000
J85.1 Abscess of lung with pneumonia	0.002	0.998	0.000
J85.0 Gangrene and necrosis of lung	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
W44 Foreign body entering into or through eye or natural orifice	0.002	0.998	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.002	0.998	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.002	0.998	0.000
C43.8 Overlapping malignant melanoma of skin	0.000	0.998	0.002
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.998	0.002
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.998	0.002
C43.0 Malignant melanoma of lip	0.000	0.998	0.002
E29.9 Testicular dysfunction, unspecified	0.002	0.998	0.000
E29.8 Other testicular dysfunction	0.002	0.998	0.000
E29.0 Testicular hyperfunction	0.002	0.998	0.000
I67.2 Cerebral atherosclerosis	0.002	0.998	0.000
M62.8 Other specified disorders of muscle	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
W29 Contact with other powered hand tools and household machinery	0.002	0.998	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.002	0.998	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.002	0.998	0.000
W25 Contact with sharp glass	0.002	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.000	0.998	0.002
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
L53.9 Erythematous condition, unspecified	0.002	0.998	0.000
M87.2 Osteonecrosis due to previous trauma	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Z39.1 Care and examination of lactating mother	0.002	0.998	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.000	0.998	0.002
A40.8 Other streptococcal septicaemia	0.002	0.998	0.000
A30-A49 Other bacterial diseases	0.002	0.998	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
M81.9 Osteoporosis, unspecified	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
I45 Other conduction disorders	0.002	0.998	0.000
W20 Struck by thrown, projected or falling object	0.002	0.998	0.000
J03.9 Acute tonsillitis, unspecified	0.002	0.998	0.000
A39 Meningococcal infection	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.002	0.998	0.000
M62.86 Other specified disorders of muscle (Lower leg)	0.000	0.998	0.002
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M94.9 Disorder of cartilage, unspecified	0.002	0.998	0.000
J85.2 Abscess of lung without pneumonia	0.002	0.998	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
M94.3 Chondrolysis	0.002	0.998	0.000
M94.1 Relapsing polychondritis	0.002	0.998	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
M87.25 Osteonecrosis due to previous trauma (Pelvic region and thigh)	0.002	0.998	0.000
A39.4 Meningococcaemia, unspecified	0.002	0.998	0.000
A49.1 Streptococcal infection, unspecified	0.002	0.998	0.000
W49.0 Home	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.002	0.998	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations